Health News Releases

  • Today August 24
June 11, 2019 10:18
New post-hoc analysis shows consistent cardiorenal risk reductions of empagliflozin in a sub-group of adults with type 2 diabetes and chronic kidney disease without overt proteinuria
Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced results of a new post-hoc analysis of data from the EMPA-REG OUTCOME® trial. These results indicated that the effect of empag
June 10, 2019 12:00
Bioventus to Co-Develop Next Generation Placental Tissue Product for Knee Osteoarthritis with MTF Biologics
Bioventus, a global leader in orthobiologic solutions, has entered into a development collaboration agreement with MTF Biologics, the world’s largest tissue bank, to co-develop a next generation place
Surgeons using Microsure‘s MUSA during a microsurgical procedure in a patient’s arm
June 10, 2019 11:58
Microsure’s MUSA Microsurgery Robot Receives CE-mark
MUSA is the world’s first surgical robot for open microsurgery. This robotic assistant is clinically and commercially available after the medical device CE-mark was issued by notified body DEKRA recen
June 10, 2019 11:57
US FDA and EMA Accept Applications for Ozanimod for the Treatment of Relapsing Forms of Multiple Sclerosis
Celgene Corporation (NASDAQ:CELG) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application for ozanimod for the treatment of people with relaps
June 07, 2019 19:17
Joe Kiani Named Honorary Academic by Mexican Academy of Surgery
The Mexican Academy of Surgery (Academia Mexicana de Cirugía A.C.), an advisory body of the Mexican Federal Government, named Joe Kiani an Honorary Academic of the organization. Kiani is the founder o
June 07, 2019 14:54
Otsuka Chemical Succeeded Part of the Cefixime Business from Astellas Pharma
Otsuka Chemical Co., Ltd. (Head office: Chuo-Ku, Osaka; President & Representative Director: Takeharu Harashima; hereinafter “Otsuka Chemical”) announces that it has succeeded part of the Cefixime bus
June 05, 2019 10:54
Takeda Presents Results from Lung Portfolio Including Phase 1/2 Study of TAK-788 in a Rare Form of NSCLC and New Data on Overall Health-Related Quality of Life for ALUNBRIG® (brigatinib)
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) today announced that new data for TAK-788 will be presented during an oral session at the 2019 American Society of Clinical Oncology (ASCO) An
June 04, 2019 09:12
New Ad-hoc Analysis of Phase 3 HELP Study™ Evaluates Prevention of HAE Attacks with TAKHZYRO® (lanadelumab) During Early Treatment Phase
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced new data from an ad-hoc analysis of the Phase 3 HELP Study™, designed to evaluate the onset of action for TAKHZYRO®
June 03, 2019 17:38
Takeda Makes First Private Sector Pledge for Global Fund Replenishment
Takeda Pharmaceutical Company Limited (“Takeda”) (TSE:4502/NYSE:TAK) today became the first private sector company to announce a financial commitment to the Global Fund’s Sixth Replenishment. The new
May 29, 2019 18:19
Boehringer Ingelheim and Gubra announce new collaboration to develop anti-obesity peptide poly-agonists
Boehringer Ingelheim and Gubra announce a second collaboration and license agreement for the development of novel poly-agonist peptides to treat obesity. It will bring together Gubra’s established exp
May 28, 2019 14:15
New Agreement Between St. George’s University and NCUK - The University Consortium Provides International Students with a Unique Pathway to Medicine
St. George’s University, the international medical school on the Caribbean island of Grenada, has announced a new agreement with NCUK - The University Consortium (NCUK), based in Manchester, United K
May 27, 2019 10:53
Pioneering Project for Pharmaceutics - Vifor Pharma and the University of Basel are Jointly Establishing the World’s First Research Professorship for Nanopharmaceutical and Regulatory Science
Nanopharmaceutics promises ground-breaking innovation in the development of medicines: · The Vifor Pharma Group is endowing two professorships for Nanopharmaceutical and Regulatory Science at the U
St. George’s University students can now complete up to two years of the Pre-clinical and Medical De
May 27, 2019 09:00
St. George's University of Grenada, Northumbria University Expand Joint Medical Education Programme
St. George’s University and Northumbria University announced an expansion of their joint medical training programme that will allow students to complete up to two years of their pre-clinical and medic
May 24, 2019 09:30
Network of 1,500 Stroke-Ready Clinics across Europe
The Angels Initiative announced today at the European Stroke Organisation Conference (ESOC) 2019 in Milan that their three-year goal to create a network of 1,500 stroke-ready centres and hospitals acr
May 23, 2019 16:02
Takeda to Showcase Growing Pipeline and Diversified Portfolio of Oncology Products at Upcoming Scientific Congresses
Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE:TAK) today announced that the company will present data at the 55th Annual Meeting of the American Society of Clinical Oncology (ASCO), May 31-Jun
May 22, 2019 11:31
ResMed Study Finds CPAP Adherence Improved by Remote Monitoring, Self-Monitoring across 3 Countries
Remote monitoring and patient self-monitoring can drive CPAP adherence for people with sleep apnea, according to research presented by ResMed (NYSE: RMD) (ASX: RMD) at the American Thoracic Society’s
May 22, 2019 09:43
Phase III study showed nintedanib slows the loss of pulmonary function in people living with systemic sclerosis associated ILD[1]
Boehringer Ingelheim today announced that the SENSCIS® trial met its primary endpoint: reduction in the annual rate of decline in forced vital capacity (FVCa) in patients with systemic sclerosis assoc
May 21, 2019 10:17
New Study Evaluates Ability of Masimo SpHb® (Noninvasive Hemoglobin) to Estimate Timing for Invasive Measurement to Detect Anemia During Surgery
Masimo (NASDAQ: MASI) announced today the results of a study published in BMC Anesthesiology in which clinicians at Peking Union Medical College in Beijing evaluated the ability of noninvasive and con
May 20, 2019 11:20
Age, Gender, Disease Severity Impact Adherence to Long-Term PAP Therapy More Than Previously Thought
ResMed (NYSE: RMD, ASX: RMD) today revealed several demographic and clinical factors affect adherence to PAP (positive airway pressure) therapy, according to a study it presented at the American Thora
May 20, 2019 10:19
New Exploratory Data from VARSITY, First Head-to-Head Ulcerative Colitis Biologic Study Which Demonstrated Superiority of Vedolizumab to Adalimumab in Clinical Remission at Week 52, Presented at 2019 Digestive Disease Week®
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced further results from the Phase 3b head-to-head VARSITY study, which demonstrated that the gut-selective biologic ve
May 20, 2019 09:42
WIN 2019 Symposium: WINnovation and Global Deployment of Precision Oncology
The 11th WIN Symposium in Precision Oncology will be held in Paris, France on June 23-24, 2019. ASCO® endorsed for the past 11 years, the WIN symposium will deliver an exciting line-up of speakers
May 17, 2019 15:32
Takeda Reports FY2018 Full Year Results and Issues FY2019 Guidance
Takeda Pharmaceutical Company Limited (TOKYO:4502)(NYSE:TAK): This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190513005951/en/ FY2018
May 17, 2019 13:44
German Diabetes Clinic Increases Diabetic Retinopathy Screenings From Zero to Thousands After Implementing Eyenuk’s EyeArt AI Eye Screening System
Eyenuk Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening™, announced today results of its expansion int
May 17, 2019 13:27
Takeda and London School of Hygiene & Tropical Medicine Establish “Takeda Chair in Global Child Health”
Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) and the London School of Hygiene & Tropical Medicine (LSHTM) will announce today at the evening reception, hosted by the Embassy
May 17, 2019 09:30
EcoTT Set on Taking over the Global Market with Hanji Safety Mask and Konjac with Dark Temptation, a Snack for Weight Control
EcoTT Co., Ltd., a Korean general trading company, announced the plan to launch its new products including Novrect Hanji Safety Mask and Konjac with Dark Temptation, a snack for weight control, on Ama
25 per page50 per page75 per page100 per page